Baxter International Inc.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $11.24B | $10.64B | $14.81B | $15.11B | $12.78B | $11.67B | $11.36B |
| Renal | — | — | — | — | — | — | — | — |
| Hospital Products | — | — | — | — | — | — | — | — |
| Americas | — | — | — | — | $6.71B | $6.67B | $6.07B | $6.09B |
| EMEA | — | — | — | — | $2.88B | $3.12B | $3.13B | $2.97B |
| APAC | — | — | — | — | $2.59B | $2.79B | $2.48B | $2.30B |
| Hillrom | — | — | — | — | $2.94B | $212.0M | — | — |
| Medical Products and Therapies | — | $5.30B | $5.21B | $5.01B | — | — | — | — |
| Healthcare Systems and Technologies | — | $3.07B | $2.95B | $3.01B | — | — | — | — |
| Pharmaceuticals | — | $2.49B | $2.41B | $2.25B | — | — | — | — |
| Kidney Care | — | — | — | $4.45B | — | — | — | — |
| Other | — | $381.0M | $67.0M | $87.0M | — | — | — | — |
| Cost of Revenue | — | $7.87B | $6.65B | $6.21B | $6.51B | $7.43B | $7.09B | $6.60B |
| Gross Profit | — | $3.38B | $3.98B | $4.15B | $3.55B | $4.72B | $4.59B | $4.76B |
| Gross Margin | — | 30.1% | 37.5% | 28.0% | 23.5% | 36.9% | 39.3% | 41.9% |
| Operating Expenses | ||||||||
| Research & Development | — | $518.0M | $590.0M | $518.0M | $450.0M | $531.0M | $521.0M | $595.0M |
| SG&A Expense | — | $2.89B | $2.97B | $2.95B | $3.10B | $2.85B | $2.47B | $2.54B |
| Operating Income | — | $-308.0M | $14.0M | $707.0M | $-2.85B | $1.35B | $1.62B | $1.77B |
| Operating Margin | — | -2.7% | 0.1% | 4.8% | -18.8% | 10.6% | 13.8% | 15.6% |
| Interest Expense | — | $290.0M | $408.0M | $508.0M | $413.0M | $207.0M | $153.0M | $111.0M |
| Pretax Income | — | $-505.0M | $-289.0M | $242.0M | $-3.25B | $1.12B | $1.29B | $970.0M |
| Income Tax Expense | — | $395.0M | $37.0M | $61.0M | $-135.0M | $83.0M | $182.0M | $-41.0M |
| Net Income | — | $-957.0M | $-649.0M | $2.66B | $-2.43B | $1.28B | $1.10B | $1.00B |
| Net Margin | — | -8.5% | -6.1% | 17.9% | -16.1% | 10.0% | 9.4% | 8.8% |
| EPS (Basic) | — | $-1.87 | $-1.27 | $5.25 | $-4.83 | $2.56 | $2.17 | $1.97 |
| EPS (Diluted) | — | $-1.87 | $-1.27 | $5.23 | $-4.83 | $2.53 | $2.13 | $1.93 |
| Shares Outstanding (Basic) | 514.5M | 513.0M | 510.0M | 506.0M | 504.0M | 502.0M | 509.0M | 509.0M |
| Shares Outstanding (Diluted) | 514.5M | 513.0M | 510.0M | 508.0M | 504.0M | 508.0M | 517.0M | 519.0M |
| Dividends Per Share | — | $0.52 | $1.04 | $1.16 | $1.15 | $1.09 | $0.96 | $0.85 |